Americas

Regional trend analysis, forecasts and market intelligence for the Pharma & Healthcare industry

Latest Americas Analysis

Industry Trend Analysis - FDA Focus On REMS Is A Substantial Victory For Generic Industry - JAN 2018

Concerns over potential Risk Evaluation and Mitigation Strategies (REMS) programme abuses have been gaining traction in 2017 at a regulatory and political level. Having already accepted that the REMS programme is potentially open to abuse to delay generic competition, the FDA is somewhat duty-bound to find solutions, and the draft guidance now issued is a first step towards addressing that, and...

READ FULL ARTICLE...

Industry Trend Analysis - New Pharmaceutical Product Portfolio Will Remain Central To Eli Lilly's Revenue Growth - DEC 2017

Eli Lilly's Q317 financial results highlight that the firm will continue to derive its growth from a broad portfolio of innovative pharmaceutical products. A range of new pharmaceutical products, spanning several therapeutic areas will drive the firm's revenue growth and will improve the long-term outlook for investors. Moreover, to maximise future value, the drugmaker will consider acquisition...

READ FULL ARTICLE...